Reston, VA-Researchers have discovered a new way to optimize results in treating patients with prostate cancer tumors while minimizing negative side effects. The study is featured in the November issue of The Journal of Nuclear Medicine.

According to the centers for disease control, “Aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. It is also one of the leading causes of cancer death among men of all races.”

To read more please visit:

https://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=33047

Source: Society of Nuclear Medicine & Molecular Imaging